Trademark: 78881284
Word
2036
Status
Dead
Status Code
606
Status Date
Thursday, April 24, 2008
Serial Number
78881284
Mark Type
4000
Filing Date
Thursday, May 11, 2006
Published for Opposition
Tuesday, July 31, 2007
Abandoned Date
Thursday, April 24, 2008

Trademark Owner History
Kindway International Limited - Owner At Publication

Classifications
5 Pharmaceutical, veterinary, and sanitary preparations, all used for the treatment of infectious diseases, namely, respiratory infections, eye infections, for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, for the treatment of neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes, for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases, for the treatment of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, for use in ophthalmology, for the treatment of dental and oral diseases, for use in gastroenterology; for the treatment of the respiratory system, for use in ocular disorders, for the treatment of cardiovascular diseases, acne medication, allergy medication, antacids, anthelmintics, anti-arrhythmics, antibiotic creams and ointments, antibiotics, anticoagulants, anticonvulsants, antidepressants, antiemetics, antiflatulants, antihistamines, antihypertensives anti-infectives, anti-inflammatories, antiparasites, antivirals, burn relief medications, calcium channels blockers, central nervous system depressants, central nervous system stimulants, cough treatment medication, diarrhea medication, fungal medications, gastro-intestinal pharmaceutical preparations, glaucoma agents, hydrocortisone, hypnotic agents, sedatives; dietetic substances, namely foods, adapted for medical use; vitamin supplements, mineral food supplements; herbal extracts for medical purposes; medicated extracts of plants and herbs in the form of capsules, tablets, liquid concentrate, powder, and crystals; dietetic supplements for medical use and nutritious health food supplement for medical use all made primarily of lingzhi spores, lingzhi spore lipids, yunzhi, bee glue or propolis, or cordyceps or extracts therefrom; lingzhi granules, lingzhi pills, lingzhi capsules, lingzhi tablets; and medicinal tea made primarily of lingzhi spores; Chinese herbal medicines, and Chinese patent medicines all composed of lingzhi spores, lingzhi spore lipids, yunzhi, bee glue, propolis, or cordyceps, and used for the treatment of infectious diseases, namely, respiratory infections, eye infections, for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, for the treatment of neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes, for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases, for the treatment of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, for use in ophthalmology, for the treatment of dental and oral diseases, for use in gastroenterology, for the treatment of the respiratory system, for use in ocular disorders, for the treatment of cardiovascular diseases, acne medication, allergy medication, antacids, anthelmintics, anti-arrhythmics, antibiotic creams and ointments, antibiotics, anticoagulants, anticonvulsants, antidepressants, antiemetics, antiflatulants, antihistamines, antihypertensives anti-infectives, anti-inflammatories, antiparasites, antivirals, burn relief medications, calcium channels blockers, central nervous system depressants, central nervous system, stimulants, cough treatment medication, diarrhea medication, fungal medications, gastro-intestinal pharmaceutical preparations, glaucoma agents, hydrocortisone, hypnotic agents, sedatives
TWO THOUSAND THIRTY-SIX

Trademark Events
Jun 25, 2008
Abandonment Notice Mailed - No Use Statement Filed
Jun 25, 2008
Abandonment - No Use Statement Filed
Oct 23, 2007
Noa Mailed - Sou Required From Applicant
Jul 31, 2007
Published For Opposition
Jul 11, 2007
Notice Of Publication
May 10, 2007
Law Office Publication Review Completed
May 2, 2007
Assigned To Lie
Apr 12, 2007
Examiners Amendment Mailed
Apr 12, 2007
Approved For Pub - Principal Register
Apr 12, 2007
Examiner's Amendment Entered
Apr 12, 2007
Examiners Amendment -Written
Apr 10, 2007
Teas/Email Correspondence Entered
Apr 9, 2007
Correspondence Received In Law Office
Apr 9, 2007
Teas Response To Office Action Received
Oct 16, 2006
Non-Final Action Mailed
Oct 16, 2006
Non-Final Action Written
Oct 14, 2006
Assigned To Examiner
Jun 26, 2006
Applicant Amendment Prior To Examination - Entered
Jun 26, 2006
Teas Voluntary Amendment Received
May 17, 2006
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24